132 related articles for article (PubMed ID: 7741645)
1. Hemodialysis with regenerated cellulosic membranes does not reduce plasma selenium levels in chronic uremic patients.
Bonomini M; Manfrini V; Marini A; De Risio F; Niri L; Klinkmann H; Albertazzi A
Artif Organs; 1995 Jan; 19(1):81-5. PubMed ID: 7741645
[TBL] [Abstract][Full Text] [Related]
2. Geographic factors and plasma selenium in uremia and dialysis.
Bonomini M; Forster S; Manfrini V; De Risio F; Steiner M; Vidovich MI; Klinkmann H; Ivanovich P; Albertazzi A
Nephron; 1996; 72(2):197-204. PubMed ID: 8684527
[TBL] [Abstract][Full Text] [Related]
3. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous multielement analysis by ICP-MS with simple whole blood sample dilution and its application to uremic patients undergoing long-term hemodialysis.
Xu B; Zhang Y; Chen Y; Zeng M; Feng J; Tang J; Yu L
Scand J Clin Lab Invest; 2020 May; 80(3):247-255. PubMed ID: 32077771
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
6. Influence of hemodialysis on selenium blood levels.
Krízek M; Senft V; Motán J
Sb Lek; 2000; 101(3):241-8. PubMed ID: 11220152
[TBL] [Abstract][Full Text] [Related]
7. Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment.
Napolitano G; Bonomini M; Bomba G; Bucci I; Todisco V; Albertazzi A; Monaco F
Biol Trace Elem Res; 1996 Dec; 55(3):221-30. PubMed ID: 9096850
[TBL] [Abstract][Full Text] [Related]
8. Selenium and glutathione levels, and glutathione peroxidase activities in blood components of uremic patients on hemodialysis supplemented with selenium and treated with erythropoietin.
Zachara BA; Adamowicz A; Trafikowska U; Trafikowska A; Manitius J; Nartowicz E
J Trace Elem Med Biol; 2001; 15(4):201-8. PubMed ID: 11846008
[TBL] [Abstract][Full Text] [Related]
9. Selenium in renal failure patients.
Milly K; Wit L; Diskin C; Tulley R
Nephron; 1992; 61(2):139-44. PubMed ID: 1630536
[TBL] [Abstract][Full Text] [Related]
10. Selenium and haemodialysis: serum selenium levels in healthy persons, non-cancer and cancer patients with chronic renal failure.
Kallistratos G; Evangelou A; Seferiadis K; Vezyraki P; Barboutis K
Nephron; 1985; 41(3):217-22. PubMed ID: 4058621
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients.
Taccone-Gallucci M; Noce A; Bertucci P; Fabbri C; Manca-di-Villahermosa S; Della-Rovere FR; De Francesco M; Lonzi M; Federici G; Scaccia F; Dessì M
J Trace Elem Med Biol; 2010 Jan; 24(1):27-30. PubMed ID: 20122576
[TBL] [Abstract][Full Text] [Related]
13. Selenium supplementation on plasma glutathione peroxidase activity in patients with end-stage chronic renal failure.
Zachara BA; Koterska D; Manitius J; Sadowski L; Dziedziczko A; Salak A; Wasowicz W
Biol Trace Elem Res; 2004 Jan; 97(1):15-30. PubMed ID: 14742897
[TBL] [Abstract][Full Text] [Related]
14. Effect of uremia and hemodialysis on soluble L-selectin and leukocyte surface CD11b and L-selectin.
Dou L; Brunet P; Dignat-George F; Sampol J; Berland Y
Am J Kidney Dis; 1998 Jan; 31(1):67-73. PubMed ID: 9428454
[TBL] [Abstract][Full Text] [Related]
15. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis.
Jaber BL; Balakrishnan VS; Cendoroglo MN; Perianayagam MC; King AJ; Pereira BJ
Blood Purif; 1998; 16(6):325-35. PubMed ID: 10343079
[TBL] [Abstract][Full Text] [Related]
16. Influence of hemodialysis membranes on gene expression and plasma levels of interleukin-1 beta.
Qian J; Yu Z; Dai H; Zhang Q; Chen S
Artif Organs; 1995 Aug; 19(8):842-6. PubMed ID: 8573006
[TBL] [Abstract][Full Text] [Related]
17. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
Linnenweber S; Lonnemann G
Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
[TBL] [Abstract][Full Text] [Related]
18. Effect of uremia and dialysis modality on mononuclear cell apoptosis.
Martín-Malo A; Carracedo J; Ramírez R; Rodriguez-Benot A; Soriano S; Rodriguez M; Aljama P
J Am Soc Nephrol; 2000 May; 11(5):936-942. PubMed ID: 10770973
[TBL] [Abstract][Full Text] [Related]
19. Selenium supplementation to chronic kidney disease patients on hemodialysis does not induce the synthesis of plasma glutathione peroxidase.
Zachara BA; Gromadzinska J; Zbrog Z; Swiech R; Wasowicz W; Twardowska E; Jablonska E; Sobala W
Acta Biochim Pol; 2009; 56(1):183-7. PubMed ID: 19238255
[TBL] [Abstract][Full Text] [Related]
20. Diminished blood selenium levels in renal failure patients on dialysis: correlations with nutritional status.
Dworkin B; Weseley S; Rosenthal WS; Schwartz EM; Weiss L
Am J Med Sci; 1987 Jan; 293(1):6-12. PubMed ID: 3812549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
